Discover how maintenance therapy with Decitabine is revolutionizing AML treatment for older adults, particularly FLT3-ITD-negative patients, based on the landmark E2906 clinical trial.
How maintenance rituximab therapy improves outcomes for mantle cell lymphoma patients who respond to bendamustine + rituximab induction therapy without autologous transplant.